With revenues falling precipitously from sales of Covid19 drugs and jabs, it's time for pharma to crank up the vaccine machine with a new market driver: vaccines for RSV. The three new shots were released almost at the same time for babies and adults, and an RSV vaccine for pregnant women is soon to be approved.  

What is RSV?

Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. According to the CDC, RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs) in children less than 1 year of age in the United States. In fact, RSV is SO common that almost all children will have had an RSV infection – and acquired natural immunity - by the time they are 2 years old.